NHS Confederation’s Post

Reflecting on our recent Human Pharma Exchange, I am inspired by the insights shared by Francesco Di Marco, our Global Head of Human Pharma Regions during his visit to the UK & Ireland. Francesco emphasized the need for communicating with candor: “We need to cut to the chase, focus on what matters, and speak with candor. This approach ensures we provide the clarity and direction needed to achieve our goals.” He also highlighted the importance of speed: “Speed is crucial because it’s not just about business performance; it’s ultimately about the patients we can serve.” These principles are vital as we strive to bring meaningful advances to patients. By communicating with candor and acting swiftly, we ensure that our teams in the UK & Ireland are aligned and focused on our ultimate goal – serving patients better and faster.

Let's look back to the remarkable achievements of the Prix Galien 2023 USA winners. 🏆 Let's take a trip down memory lane and remember the extraordinary innovations that continue to shape the landscape of healthcare. To Bristol Myers Squibb, Eli Lilly and Company, Boehringer Ingelheim, CSL / uniQure, Guardant Health, Medable, Inc, Villgro Africa, GrayMatters Health, and Volta Medical: Your contributions have left an indelible mark on the world of healthcare. Your vision, dedication, and unwavering commitment to excellence have inspired us all. As we reflect on this special moment, we're reminded of the boundless potential of human ingenuity and the power of innovation to transform lives. Here's to the enduring legacy of the Prix Galien winners and the hope they continue to bring to patients worldwide. Join us in honoring these visionary leaders and innovators as we look back on a year filled with groundbreaking achievements. #throwbackthursday #PrixGalien #healthcareinnovation #medicalresearch #pharmaceuticalindustry #biotechnology

'Innovation or Stagnation? The Future of Europe's Healthcare' - Stefan Woxström, SVP, AstraZeneca Europe & Canada at Pharma 2024 addresses why innovation is key to building resilient and sustainable health systems across Europe and how we can harness the power of public-private partnerships. #REpharma2024

Last week, USP welcomed a delegation of senior executives and leaders from Mexico's Asociación Mexicana de Laboratorios Farmacéuticos (AMELAF) in Rockville, MD. This meeting marks an important milestone in USP's ongoing engagement with industry leaders in Mexico, building upon AMELAF joining USP as a Convention member last year. The highlight of the meeting was the signing of a memorandum of understanding between AMELAF and USP, starting a new chapter of collaboration. • USP and AMELAF will establish a consistent channel for sharing vital insights on emerging quality challenges and best practices in effectively applying quality standards. • The organizations will collaborate on targeted training programs and knowledge-sharing activities aimed at strengthening quality assurance systems and standard-setting. • We will work together to advance long-term strategies promoting sustainable access to quality-assured medicines. By combining USP and AMELAF's expertise in standards-setting, shared goals, and local and global networks, the collaboration aims to accelerate progress toward delivering quality medicines to patients in Mexico and globally. Stay tuned for updates on this collaboration! Juan de Villafranca

🔥 The countdown is on, and the excitement is palpable! Two weeks from now, you will have the opportunity to elevate your game, expand your horizons and, live the ReImagine Pharma Marketing Experience! ✅Explore how AI tools can be implemented in your marketing efforts to maximize resources and deliver effective messages while enhancing targeting capabilities. ✅Discuss how Social Media platforms function as search engines, the advantages and challenges they present, and how marketers can leverage this trend to connect with their target audience. ✅ReImagine the Legal Review Process to streamline the review process, understanding the risk tolerance of your company. Don't miss your chance to be a part of this electrifying journey! 🎊 Apply for one of the last VIP PASSES HERE : https://cvent.me/LNwBOD #ReImaginePharma #PharmaMarketingRevolution #InnovationUnleashed #HealthcareInnovators #MarketingExcellence #FutureOfHealthcare #PharmaIndustry https://lnkd.in/dxQaGUAT

Have you heard of Pharmageddon? Do you wish you'd attended or perhaps you're sitting on the fence questioning if this disruptive pharma event is actually valuable. Find the answers to these questions AND how to escape the Pharma status quo to change our industry for the benefit of patients in by reading the Pharmageddon EU24 post event report: https://lnkd.in/eWruYM96

The opportunity to build frameworks that will accelerate access is in reach. Join this exclusive Reuters Events webinar on Feb 28 to hear from Otsuka, Biogen, Boehringer Ingelheim and Novartis: https://bit.ly/3UdYRHY This discussion will also cover: • Streamline access pathways: Learn to navigate legislative changes confidently to establish pricing frameworks that prioritize patient accessibility • Patient-centric negotiations: Integrate patient perspectives into early-stage pipeline development and planning to ensure success in payer negotiations • Harnessing real-world data: Explore the power of patient-focused RWD in informing clinical trials to strengthen your value proposition for payers • Build lasting relationships: Co-create value-based agreements with healthcare systems to foster enduring relationships with payers Sign-up here for free live and on-demand access: https://bit.ly/3UdYRHY Don’t miss out! #marketaccess #rwe #rwd

The opportunity to build frameworks that will accelerate access is in reach. Join this exclusive Reuters Events webinar on Feb 28 to hear from Otsuka, Biogen, Boehringer Ingelheim and Novartis: https://bit.ly/3UdYRHY This discussion will also cover: • Streamline access pathways: Learn to navigate legislative changes confidently to establish pricing frameworks that prioritize patient accessibility • Patient-centric negotiations: Integrate patient perspectives into early-stage pipeline development and planning to ensure success in payer negotiations • Harnessing real-world data: Explore the power of patient-focused RWD in informing clinical trials to strengthen your value proposition for payers • Build lasting relationships: Co-create value-based agreements with healthcare systems to foster enduring relationships with payers Sign-up here for free live and on-demand access: https://bit.ly/3UdYRHY Don’t miss out! #marketaccess #rwe #rwd

The opportunity to build frameworks that will accelerate access is in reach. Join this exclusive Reuters Events webinar on Feb 28 to hear from Otsuka, Biogen, Boehringer Ingelheim and Novartis: https://bit.ly/3UdYRHY This discussion will also cover: • Streamline access pathways: Learn to navigate legislative changes confidently to establish pricing frameworks that prioritize patient accessibility • Patient-centric negotiations: Integrate patient perspectives into early-stage pipeline development and planning to ensure success in payer negotiations • Harnessing real-world data: Explore the power of patient-focused RWD in informing clinical trials to strengthen your value proposition for payers • Build lasting relationships: Co-create value-based agreements with healthcare systems to foster enduring relationships with payers Sign-up here for free live and on-demand access: https://bit.ly/3UdYRHY Don’t miss out! #marketaccess #rwe #rwd